Cargando…
Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands
Autores principales: | Dinmohamed, Avinash G, Visser, Otto, Verhoeven, Rob H A, Louwman, Marieke W J, van Nederveen, Francien H, Willems, Stefan M, Merkx, Matthias A W, Lemmens, Valery E P P, Nagtegaal, Iris D, Siesling, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252180/ https://www.ncbi.nlm.nih.gov/pubmed/32359403 http://dx.doi.org/10.1016/S1470-2045(20)30265-5 |
Ejemplares similares
-
Relative survival in early-stage cancers in the Netherlands: a population-based study
por: Dinmohamed, Avinash G., et al.
Publicado: (2020) -
Number of life-years lost at the time of diagnosis and several years post-diagnosis in patients with solid malignancies: a population-based study in the Netherlands, 1989–2019
por: Maas, Carolien C.H.M., et al.
Publicado: (2023) -
The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands
por: Dinmohamed, Avinash G., et al.
Publicado: (2020) -
Survival in Primary Myelofibrosis: A Population-based Analysis in the Netherlands
por: Slot, Stefanie, et al.
Publicado: (2021) -
Innovations in CKRT: individualized therapy with fewer complications
por: Szamosfalvi, Balazs, et al.
Publicado: (2020)